GlassScriptPhysician profile
Rashad E Dabaghi
NPI 1174508758
$1,780.62
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,499 · 2020: $244 · 2021: $37.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $333.73 | 2019-2020 | |
| Pfizer INC. | $298.34 | 2019 | |
| Abbvie INC. | $279.34 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $234.27 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $208.85 | 2019 | |
| Gilead Sciences, INC. | $136.81 | 2019-2020 | |
| Shire North American Group INC | $49.88 | 2019 | |
| Celgene Corporation | $37.39 | 2021 | |
| Ironwood Pharmaceuticals, INC | $30.67 | 2019 | |
| Romark Laboratories, Lc | $27.02 | 2020 | |
| Intercept Pharmaceuticals, INC. | $26.15 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.33 | 2019 | |
| Allergan, INC. | $19.78 | 2019 | |
| Merck Sharp & Dohme LLC | $16.12 | 2019 | |
| Alfasigma USA, INC. | $14.94 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $14.14 | 2019 | |
| Redhill Biopharma INC. | $12.20 | 2020 | |
| Janssen Biotech, INC. | $11.21 | 2019 | |
| Qol Medical, LLC | $6.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashad Dabaghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.